你即將離開本站

並前往https://techtransfer.universityofcalifornia.edu/NCD/32765.html

Cyclic Peptide Ligands of the Oncoprotein KRAS (G12D)

Within this family, KRAS mutations account for 83% and occur in ~11% of all cancers. Several KRAS mutation variants exist with KRAS (G12D) being the most ...

確定！ 回上一頁

查詢 「KRAS G12D」的人也找了：

  1. KRAS G12D inhibitor
    2.
  2. kras基因
    3.
  3. Sotorasib
    4.
  4. kras是什麼
    5.
  5. KRAS G12C
    6.
  6. KRAS mutation
    7.
  7. KRAS G12D lung cancer
    8.
  8. kras突變
    9.